Patient Management

2074 soru

Soru 1041Soru →

A 28-year-old man recently diagnosed with HIV infection returns to the clinic to discuss his laboratory results. His CD4 cell count is 650/mm³ and his HIV viral load is 45,000 copies/mL. He is currently asymptomatic and has no other medical conditions. During the visit, the physician recommends initiating daily antiretroviral therapy (ART). The patient crosses his arms, shakes his head, and says, "I have been reading a lot online, and I decided I am not going to take those toxic chemicals. I feel perfectly fine right now. I will only consider taking them if my immune system actually starts failing and I get sick." Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: It is understandable that you want to avoid toxicities. Can you tell me more about the specific side effects you are most concerned about?

Cevap

The most appropriate response is to validate the patient's concerns and ask an open-ended question to explore specific fears about medication side effects.
The initial step in patient counseling and health education, especially when encountering treatment refusal or hesitancy, is to explore the patient's underlying illness representation and specific fears. This patient-centered approach builds a therapeutic alliance and identifies the exact educational gaps that need to be addressed. Using open-ended questions to explore concerns about medication toxicity validates the patient's autonomy while gathering necessary information to provide targeted education in the subsequent steps of the interview.

Adım Adım Çözüm

1
Analyze the patient's statement and emotional state.
The patient is asymptomatic, hesitant to start ART due to fear of "toxic chemicals," and believes treatment is only necessary for symptomatic disease.
Understanding the patient's perspective and illness representation is required before implementing any educational or therapeutic intervention.
2
Evaluate clinical and ethical constraints.
The patient is an adult who appears to have decision-making capacity. Coercion, threats of mandatory reporting, or paternalistic demands are ethically prohibited and counterproductive.
Maintaining the therapeutic alliance while respecting patient autonomy is the standard of care in outpatient counseling.
3
Select the best communication strategy.
Choose a response that validates the patient's concern without agreeing with incorrect facts, and ask an open-ended question to gather more information.
This approach reduces defensiveness and facilitates targeted health education and collaborative decision-making.

Anahtar Kavram

Patient-centered counseling and exploring illness beliefs
Soru 1042Soru →

Review the following patient presentations from today's primary care clinic. For each patient, select the single most appropriate next step in preventive care based on current United States Preventive Services Task Force (USPSTF) guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 66-year-old male patient with a 40 pack-year smoking history, currently smoking. He is up to date on colonoscopy, annual low-dose chest CT, and lipid panel testing. No previous imaging of the abdomen has been recorded.
An active, healthy 66-year-old female who has never smoked. Her records indicate recent normal results for screening mammography, colonoscopy, and routine metabolic blood work.
A 52-year-old woman who previously smoked 1 pack per day for 15 years before quitting 20 years ago. She had a normal colonoscopy and cervical cytology two years ago. Her most recent breast imaging was completed at age 48.
An asymptomatic 24-year-old female patient who is sexually active with a new male partner. She has never smoked. A routine cervical cytology test performed 6 months ago was normal.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Match the 66-year-old male to one-time abdominal ultrasonography, the 66-year-old female to dual-energy x-ray absorptiometry, the 52-year-old woman to screening mammography, and the 24-year-old female to nucleic acid amplification testing for Chlamydia trachomatis.
Each patient accurately fulfills a specific, evidence-based USPSTF Grade A or B recommendation for screening interventions based on their exact combination of biological sex, age, and risk exposures.

Adım Adım Çözüm

1
Evaluate the 66-year-old male patient's risk profile.
He requires AAA screening.
He falls into the 65-75 age range for men and has a positive smoking history, meeting the criteria for a one-time abdominal ultrasound.
2
Assess the healthy 66-year-old female patient.
She requires osteoporosis screening.
All women aged 65 and older meet the age-based criteria for a screening DEXA scan, regardless of other risk factors.
3
Review the history of the 52-year-old woman with a remote smoking history.
She requires screening mammography.
She is due for her biennial mammogram. Her smoking history (15 pack-years, quit 20 years ago) falls short of the current criteria for LDCT lung cancer screening.
4
Analyze the preventive needs of the 24-year-old sexually active female.
She requires Chlamydia screening.
She is up to date on her cervical cytology (Pap smear), but current guidelines mandate STI screening (Chlamydia and Gonorrhea) for sexually active women aged 24 and younger.

Anahtar Kavram

Age, sex, and risk-factor specific preventive screening modalities (USPSTF guidelines).
Soru 1043Soru →

A 42-year-old woman is evaluated in the clinic prior to a change in her medication regimen. She has a 4-year history of seropositive rheumatoid arthritis. For the past year, she has been managed with sulfasalazine and hydroxychloroquine, but she reports persistent morning stiffness lasting over two hours and increasing pain in her wrists and hands. Examination shows synovitis with effusions in the bilateral wrists, metacarpophalangeal joints, and proximal interphalangeal joints. Radiographs of the hands reveal new periarticular erosions. The physician decides to discontinue sulfasalazine and initiate therapy with methotrexate and infliximab. The patient has no history of cardiovascular or liver disease, and her physical examination is otherwise unremarkable. Which of the following baseline screening tests are strictly required before initiating this new pharmacologic regimen? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Interferon-gamma release assay; Hepatitis B surface antigen and core antibody

Cevap

The required baseline screening tests before initiating a TNF-alpha inhibitor and methotrexate are an interferon-gamma release assay (or tuberculin skin test) and hepatitis B surface antigen and core antibody testing.
The correct baseline monitoring parameters for a patient starting a tumor necrosis factor (TNF)-alpha inhibitor (infliximab) and methotrexate include an interferon-gamma release assay (or tuberculin skin test) and hepatitis B surface antigen and core antibody testing. TNF-alpha is essential for maintaining granulomas that sequester Mycobacterium tuberculosis. Inhibiting TNF-alpha greatly increases the risk of reactivating latent tuberculosis infection, making baseline screening mandatory. Furthermore, both methotrexate and TNF-alpha inhibitors are potent immunosuppressants associated with a significant risk of hepatitis B reactivation, which can lead to fulminant hepatic failure. Consequently, all patients must have baseline serologic testing for hepatitis B prior to initiating therapy.

Adım Adım Çözüm

1
Identify the proposed high-risk pharmacotherapy.
The patient is being started on a TNF-alpha inhibitor (infliximab) and a disease-modifying antirheumatic drug (methotrexate).
Different immunosuppressive medications have unique adverse effect profiles and require specific baseline screening protocols.
2
Determine the infectious disease screening requirements for TNF-alpha inhibitors.
TNF-alpha inhibitors require baseline screening for latent tuberculosis and hepatitis B due to the high risk of fatal reactivation.
TNF-alpha is crucial for granuloma maintenance (preventing tuberculosis dissemination) and viral clearance.
3
Evaluate the need for other proposed screening tests based on patient factors and drug mechanisms.
Routine echocardiography, TPMT testing, and ANA/anti-dsDNA screening are not indicated for this specific drug combination in an asymptomatic patient.
Screening must be evidence-based and directly tailored to the specific risks of the prescribed medications, avoiding unnecessary testing based on unrelated contraindications.

Anahtar Kavram

Prior to initiating TNF-alpha inhibitors (e.g., infliximab) and methotrexate, patients must undergo baseline screening for latent tuberculosis (via IGRA or tuberculin skin test) and hepatitis B (via surface antigen and core antibody testing) to prevent severe disease reactivation.
Soru 1044Soru →

A hospital ethics committee is reviewing several complex cases regarding end-of-life decision-making and patient autonomy. Pair each patient vignette with the foundational ethical principle or legal standard that best justifies the clinical action taken.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A physician administers high-dose intravenous phenobarbital for refractory terminal restlessness in a dying patient with pancreatic cancer, accepting the secondary risk of fatal respiratory depression.
A designated healthcare proxy refuses hemodialysis for an unconscious trauma patient, referencing multiple past conversations where the patient explicitly rejected life-sustaining treatments if severely neurologically compromised.
A court-appointed guardian authorizes a transition to hospice care for a patient with lifelong profound intellectual disability and terminal metastatic disease, as the patient never possessed the capacity to formulate personal healthcare values.
A fully oriented and competent patient with advanced amyotrophic lateral sclerosis (ALS) formally declines the placement of a percutaneous endoscopic gastrostomy (PEG) tube, fully acknowledging that this decision will result in starvation and death.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios correctly map as follows: the administration of phenobarbital for restlessness aligns with the Principle of Double Effect; the proxy following prior explicit wishes aligns with Substituted Judgment; the guardian acting for a lifelong incapacitated patient aligns with the Best Interests standard; and the competent ALS patient declining a PEG tube aligns with Informed Refusal.
Each matching correctly aligns the clinical context with its governing ethical framework. The Principle of Double Effect protects clinicians providing aggressive symptom management at the end of life when the primary intent is relief, not death. Substituted judgment requires a surrogate to act exactly as the patient would have, necessitating prior known values. The Best Interests standard is reserved for patients whose wishes are unknown or who never possessed capacity. Informed refusal is the fundamental right of a competent adult to decline unwanted care.

Adım Adım Çözüm

1
Analyze the pancreatic cancer vignette to identify the intent versus the secondary outcome.
The intent is symptom relief, with an accepted risk of hastening death.
This dual-outcome scenario requires the application of the Principle of Double Effect.
2
Evaluate the trauma patient vignette to identify the basis of the surrogate's decision.
The proxy uses the patient's previously expressed wishes.
When decisions are made based on what the patient would have wanted, the Substituted Judgment standard applies.
3
Assess the intellectual disability vignette to determine how decisions are made for patients lacking prior capacity.
The guardian must weigh clinical burdens and benefits because the patient's autonomous values are unknown.
Without prior capacity, the Substituted Judgment standard cannot be used, leaving the Best Interests standard as the appropriate framework.
4
Review the ALS vignette to evaluate a competent patient's right to decline care.
The patient possesses capacity and rejects life-sustaining intervention.
This is a direct exercise of the Informed Refusal doctrine.

Anahtar Kavram

Ethical and legal frameworks for end-of-life decision-making
Soru 1045Soru →

Emergency medical services bring a 79-year-old male to the emergency department due to severe shortness of breath. The patient has a known history of end-stage heart failure with reduced ejection fraction and stage 5 chronic kidney disease (baseline creatinine 3.9 mg/dL). Upon arrival, he is lethargic, obtunded, and incapable of meaningfully participating in his medical care. He exhibits profound respiratory distress with prominent use of accessory muscles.

His daughter accompanies him and provides the physician with legal documentation establishing her as the designated healthcare proxy, alongside a valid advance directive. The directive explicitly refuses endotracheal intubation and cardiopulmonary resuscitation, requesting only symptom-directed comfort care. Shortly thereafter, the patient's estranged son arrives. He becomes visibly upset, demanding that the patient be immediately intubated and transferred to the intensive care unit, threatening litigation if aggressive life-sustaining measures are withheld.

The attending physician concludes that intubation contradicts both the documented advance directive and the proxy's instructions. Meanwhile, the daughter urgently asks for medications to relieve her father's severe breathing difficulty.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Administer low-dose intravenous hydromorphone and admit the patient for comfort-focused care

Cevap

Administer low-dose intravenous hydromorphone and admit the patient for comfort-focused care.
The most appropriate next step is to administer low-dose intravenous hydromorphone to relieve the patient's severe dyspnea and admit him for comfort-focused care. The patient lacks clinical decision-making capacity, so his legally designated healthcare proxy (the daughter) has the authority to direct his care. Her request aligns with the patient's valid advance directive, which refuses intubation. Therefore, the estranged son's demands must be respectfully declined. Furthermore, for managing dyspnea in a patient with severe chronic kidney disease, hydromorphone or fentanyl is preferred over morphine because morphine has active metabolites (e.g., morphine-6-glucuronide) that accumulate in renal failure and cause significant neurotoxicity.

Adım Adım Çözüm

1
Assess the patient's clinical capacity to make medical decisions.
The patient is lethargic and obtunded, meaning he lacks the clinical capacity to direct his own care.
Establishing capacity determines whether the patient or a surrogate decision-maker has authority over current treatment choices.
2
Identify the legally appropriate surrogate decision-maker.
The daughter is the designated healthcare proxy and presents a valid advance directive.
A legally appointed healthcare proxy supersedes the wishes of other family members, such as the estranged son, within the surrogate hierarchy.
3
Select the appropriate pharmacological intervention for refractory dyspnea in the setting of severe renal impairment.
Intravenous hydromorphone is chosen to relieve distress.
Opioids are the treatment of choice for end-of-life dyspnea. Hydromorphone is preferred over morphine in stage 5 chronic kidney disease to prevent the accumulation of neurotoxic metabolites.

Anahtar Kavram

When a patient lacks clinical capacity, medical decisions are guided by their advance directive and legally designated healthcare proxy, superseding conflicting demands from other family members. Refractory dyspnea at the end of life is managed with opioids, utilizing agents like hydromorphone for patients with severe chronic kidney disease to avoid metabolite toxicity.
Tahmini Süre:1m 30s
Soru 1046Soru →

During an annual wellness evaluation, a physician is discussing preventive health measures with a healthy individual who recently turned 52. The individual has a 35-pack-year smoking history and currently smokes one pack of cigarettes daily. When the physician introduces the topic of low-dose computed tomography for lung cancer screening, the individual abruptly crosses their arms and says, "I am not doing any cancer tests. Every time I come here, I get a lecture about my habits. My uncle smoked his whole life and died peacefully at 95." Which of the following is the most appropriate initial communication strategy for the physician to employ?

Cevabı ve açıklamayı göster

Cevap: It sounds like you feel frustrated when we discuss your smoking. Can we explore your specific concerns about the lung scan?

Cevap

The most appropriate response uses reflective listening to acknowledge the patient's frustration without judgment, followed by an open-ended question to explore their specific reservations about the screening test.
The correct response utilizes reflective listening to validate the patient's emotional experience without agreeing with their behavior. By stating, 'It sounds like you feel frustrated...', the physician de-escalates the patient's defensiveness. This is immediately followed by an open-ended question to gently steer the conversation back to the specific screening test, fostering a collaborative patient-physician relationship rather than an adversarial one.

Adım Adım Çözüm

1
Analyze the patient's emotional state and primary barrier.
The patient is defensive and expects to be judged or lectured regarding their smoking habits.
Recognizing the underlying emotion is required before any medical facts or guidelines can be successfully communicated.
2
Evaluate the communication options based on principles of motivational interviewing.
Responses that argue, threaten, or prematurely pivot to medical management will increase patient resistance.
Directly challenging a defensive patient damages the therapeutic alliance and violates patient-centered counseling principles.
3
Select the response that builds rapport and addresses the emotional barrier.
The response validating the patient's frustration and asking an open-ended question is chosen.
Reflective listening de-escalates tension and allows the physician to smoothly transition back to discussing the screening test collaboratively.

Anahtar Kavram

Handling Patient Resistance and Reflective Listening
Tahmini Süre:1m 0s
Soru 1047Soru →

A 54-year-old biological female presents to the clinic for a routine health maintenance visit. Her medical history is significant for hypertension, hyperlipidemia, and chronic kidney disease stage 3a with a baseline estimated glomerular filtration rate of 52 mL/min/1.73 m². She is a former smoker who smoked 1.5 packs of cigarettes per day from age 37 to age 49 (a total of 12 years) before quitting completely 5 years ago. Current medications include lisinopril and rosuvastatin. Her body mass index is 29 kg/m².

Vaccination history:
- Up to date on seasonal influenza and COVID-19 vaccines.
- Received a Tdap booster 4 years ago after a minor kitchen laceration.
- Received two doses of the recombinant zoster vaccine at age 51.
- She has never received a pneumococcal vaccine.

Screening history:
- Screening colonoscopy at age 48 was completely normal.
- Pap smear with HPV co-testing 3 years ago was negative for intraepithelial lesion or malignancy.
- Hepatitis C virus antibody testing at age 50 was negative.
- Screening mammography 11 months ago was interpreted as BI-RADS 1 (negative).

Which of the following is the most appropriate next step in preventive care and screening for this patient today?

Cevabı ve açıklamayı göster

Cevap: Administration of 20-valent pneumococcal conjugate vaccine

Cevap

Administration of 20-valent pneumococcal conjugate vaccine
The correct answer is the administration of the 20-valent pneumococcal conjugate vaccine (PCV20). According to current ACIP guidelines, adults aged 19-64 with certain underlying medical conditions—including chronic kidney disease (CKD), chronic heart or lung disease, diabetes, and current smoking—are at increased risk for pneumococcal disease and should receive pneumococcal vaccination. Because this patient has CKD stage 3a and has never received a pneumococcal vaccine, a single dose of PCV20 is indicated today.

Adım Adım Çözüm

1
Calculate the patient's smoking pack-years to evaluate lung cancer screening eligibility.
1.5 packs per day multiplied by 12 years equals 18 pack-years.
USPSTF guidelines require a minimum of 20 pack-years for low-dose CT screening. She fails to meet this quantitative threshold.
2
Review the patient's current age and chronic medical conditions against ACIP immunization schedules.
The patient is 54 years old and has chronic kidney disease (CKD) stage 3a.
While routine pneumococcal vaccination begins at age 65, adults aged 19-64 with specific high-risk conditions (including CKD) are indicated to receive it early.
3
Verify the intervals of her recent cancer screenings.
Mammogram was 11 months ago (due every 2 years), Pap/HPV was 3 years ago (due every 5 years), and colonoscopy was 6 years ago (due every 10 years).
Ensures no routine cancer screenings are prematurely ordered before their guideline-directed intervals.

Anahtar Kavram

Application of quantitative thresholds in preventive screening and condition-specific immunization indications for adults under 65.
Tahmini Süre:1m 30s
Soru 1048Soru →

A 42-year-old woman visits the outpatient clinic for a general wellness examination. She feels well and has no specific health concerns. Her medical history is unremarkable, and she takes no daily medications. Her family history is notable for a mother with cervical cancer at age 55, but there is no family history of breast, ovarian, or colon cancer. Menarche occurred at age 13, and she has regular menstrual cycles. Vital signs are within normal limits. Physical examination, including a clinical breast examination, reveals no abnormalities. She has never undergone any breast imaging.

Based on current United States Preventive Services Task Force (USPSTF) guidelines, which of the following is the most appropriate next step in management for this patient?

Cevabı ve açıklamayı göster

Cevap: Order a screening mammogram

Cevap

Order a screening mammogram
The correct action is to order a screening mammogram. The United States Preventive Services Task Force (USPSTF) updated its guidelines to recommend biennial screening mammography for all average-risk women starting at age 40 and continuing until age 74. Because this patient is 42 years old and has never undergone breast imaging, it is clinically indicated to initiate screening at this wellness visit.

Adım Adım Çözüm

1
Identify the patient's demographic and breast cancer risk profile.
The patient is a 42-year-old female with a normal breast examination and no family history of breast or ovarian cancer, placing her at average risk.
Risk stratification dictates the appropriate screening modality and the starting age for interventions.
2
Apply the current United States Preventive Services Task Force (USPSTF) breast cancer screening guidelines.
The USPSTF recommends biennial screening mammography for all women aged 40 to 74 years.
Standardizing care using current evidence-based guidelines ensures early detection and reduces mortality.
3
Determine the next best step in management for this specific patient.
Because she is 42 years old and has never been screened, the immediate next step is to order a screening mammogram.
Initiating screening now aligns perfectly with the recommendation to start at age 40.

Anahtar Kavram

The USPSTF recommends biennial screening mammography for all women aged 40 to 74 years.
Soru 1049Soru →

Match each patient presentation from the primary care clinic with the most appropriate next step in preventive screening according to current United States Preventive Services Task Force (USPSTF) guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

21-year-old healthy female presenting for her first well-woman examination
58-year-old male with a 30-pack-year smoking history who currently smokes
68-year-old female with no history of fractures presenting for a routine check-up
46-year-old average-risk male presenting for an annual physical evaluation

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 21-year-old female should receive cervical cytology; the 58-year-old male smoker should undergo a low-dose CT of the chest; the 68-year-old female requires a DEXA scan; and the 46-year-old male should begin colorectal cancer screening.
Each patient demographic profile aligns exclusively with one major Grade A or B USPSTF recommendation. Age 21 is the universal starting point for cervical screening. Age 45 is the universal starting point for colorectal cancer screening. Age 65 is the universal starting point for osteoporosis screening in women. Age 50 combined with a 20 pack-year smoking history serves as the threshold for lung cancer screening.

Adım Adım Çözüm

1
Assess the 21-year-old female's screening requirements based on age.
Identify the need for cervical cancer screening.
Guidelines mandate the initiation of Pap smears at age 21 for all individuals with a cervix.
2
Evaluate the 58-year-old male's risk factors.
Identify the need for lung cancer screening.
His age and 30-pack-year smoking history meet the strict criteria for annual LDCT.
3
Determine the age-based screening needs for the 68-year-old female.
Identify the need for osteoporosis screening.
All women aged 65 and older qualify for baseline DEXA scanning.
4
Review the 46-year-old male's gastrointestinal cancer screening eligibility.
Identify the need for colorectal screening.
The initiation age for average-risk colorectal cancer screening is 45 years.

Anahtar Kavram

Age and risk-based application of USPSTF preventive screening guidelines.
Soru 1050Soru →

A 70-year-old male presents to the clinic to establish primary care. He has not seen a physician in over a decade. His past medical history is significant for severe chronic obstructive pulmonary disease (COPD) requiring continuous home oxygen therapy (FEV1 32% of predicted), and ischemic cardiomyopathy with a left ventricular ejection fraction of 25% and NYHA Class III symptoms. He reports being housebound due to dyspnea on minimal exertion. He currently feels at his baseline and denies abdominal pain, changes in bowel habits, or rectal bleeding. A complete blood count reveals a hemoglobin of 14.5 g/dL. He has never undergone colorectal cancer screening but asks if he should be tested now because a close friend was recently diagnosed with colon polyps. Which of the following is the most appropriate next step regarding colorectal cancer screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Advise the patient that screening is not indicated

Cevap

Advise the patient that screening is not indicated due to his severe, life-limiting comorbidities and limited life expectancy.
Colorectal cancer screening is generally recommended for adults aged 45 to 75. However, major medical societies explicitly emphasize that screening should be individualized. It is most appropriate for adults who are healthy enough to undergo treatment if cancer is detected and who do not have life-limiting comorbid conditions. This patient has severe, end-stage cardiopulmonary disease (oxygen-dependent COPD and NYHA Class III heart failure). His life expectancy is severely limited (well under 10 years), meaning he will not realize the long-term mortality benefits of detecting a slow-growing cancer. Furthermore, the procedural risks of colonoscopy (sedation-related respiratory failure or hemodynamic collapse) vastly outweigh the benefits. Because he cannot safely undergo a colonoscopy, even non-invasive initial screening tests are inappropriate, as a positive result cannot be safely evaluated. Therefore, the most appropriate step is to advise against screening.

Adım Adım Çözüm

1
Evaluate the patient's age and general screening indication.
The patient is 70 years old, which falls within the standard age range (45-75 years) for routine colorectal cancer screening.
Age is the primary determinant for initiating routine population-based screening.
2
Assess the patient's overall health status and life expectancy.
The patient has oxygen-dependent COPD and NYHA Class III ischemic cardiomyopathy, significantly limiting his life expectancy to less than 10 years.
Preventive screening requires a sufficient life expectancy (typically > 10 years) for the patient to realize a mortality benefit from the detection and treatment of early-stage cancer.
3
Evaluate the risks associated with the screening pathway.
Diagnostic colonoscopy would carry an unacceptably high risk of sedation-related cardiopulmonary collapse.
If a non-invasive test (like a fecal immunochemical test) is positive, a colonoscopy is mandatory. You cannot safely complete the screening cascade.
4
Determine the most appropriate management plan.
Discontinue or advise against screening through shared decision-making.
When procedural risks outweigh theoretical benefits and life expectancy is short, withholding screening is the standard of care.

Anahtar Kavram

Individualization of cancer screening based on life expectancy and comorbidities.
Soru 1051Soru →

A 54-year-old woman comes to the clinic to discuss her recent laboratory results and health maintenance plan. She has a 10-year history of type 2 diabetes mellitus and chronic kidney disease stage 3a (estimated glomerular filtration rate of 52 mL/min/1.73 m²). Her current medications include metformin, sitagliptin, and lisinopril. Today, her hemoglobin A1c is 9.1%, and her blood pressure is 138/86 mm Hg.

During the visit, the patient expresses frustration: "I know my blood sugar is still high, but I am absolutely terrified of starting insulin. My grandmother started insulin and was on dialysis a year later; I don't want that to happen to me. Instead, I'd rather just take over-the-counter naproxen to help with my new leg pain so I can walk more. Also, I don't think I need to schedule that mammogram you mentioned last time, since nobody in my family has ever had breast cancer."

Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: It sounds like you have significant concerns about insulin leading to dialysis. Can you tell me more about your grandmother's experience?

Cevap

The most appropriate response is to validate the patient's concerns about insulin and dialysis, and ask her to elaborate on her grandmother's experience.
The correct response utilizes patient-centered communication by validating the patient's emotional state and exploring her specific health beliefs (often termed the explanatory model). Many patients associate insulin with end-stage complications because they observe family members starting insulin late in their disease course. By asking the patient to elaborate on her grandmother's experience, the physician builds trust, uncovers the root of the hesitancy, and creates an opportunity to provide targeted health education (e.g., explaining that uncontrolled diabetes, not insulin, causes kidney failure).

Adım Adım Çözüm

1
Analyze the patient's statements and requests.
The patient exhibits insulin hesitancy based on an associative belief (insulin causes dialysis), requests an NSAID for leg pain, and declines breast cancer screening due to lack of family history.
Identifying all clinical and psychological barriers is necessary before formulating a management plan.
2
Evaluate the clinical safety and appropriateness of the patient's requests.
Naproxen is contraindicated due to her chronic kidney disease. Breast cancer screening is indicated at age 54 regardless of family history. New leg pain requires medical evaluation, not assumptions.
Physicians must recognize when patient requests conflict with medical guidelines, contraindications, or safe diagnostic practices.
3
Select the communication strategy that addresses the core emotional barrier without committing clinical errors.
Exploring the patient's illness narrative regarding her grandmother is chosen as the safest and most effective initial step.
Effective health education requires understanding the patient's 'explanatory model' before attempting to correct medical misconceptions or enforce adherence.

Anahtar Kavram

Patient-Centered Interviewing and Health Education
Soru 1052Soru →

A 55-year-old man presents to the clinic for a routine health maintenance visit. His medical history is significant for type 2 diabetes mellitus and primary hypertension. He has a 30-pack-year smoking history and continues to smoke half a pack of cigarettes daily. His surgical history is unremarkable. His last colonoscopy was performed exactly 10 years ago at age 45 and was normal. His immunizations are up to date, including an annual influenza vaccine, a Tdap booster 2 years ago, and a completed recombinant zoster vaccine series at age 50. He has never received a pneumococcal vaccine. His records show a negative one-time hepatitis C antibody test at age 50. He has no specific health complaints, new skin lesions, or vision changes today.

Based on current United States Preventive Services Task Force (USPSTF) and Advisory Committee on Immunization Practices (ACIP) guidelines, which of the following preventive interventions are indicated for this patient today? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Screening for lung cancer with low-dose computed tomography (LDCT); Screening for colorectal cancer with colonoscopy; Administration of the 20-valent pneumococcal conjugate vaccine (PCV20)

Cevap

The indicated interventions are screening for lung cancer with low-dose computed tomography (LDCT), screening for colorectal cancer with colonoscopy, and administration of the 20-valent pneumococcal conjugate vaccine (PCV20).
This patient requires multiple preventive interventions based on his age, comorbidities, and social history. According to USPSTF guidelines, annual lung cancer screening with low-dose computed tomography (LDCT) is recommended for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or have quit within the past 15 years. This 55-year-old current smoker with a 30 pack-year history meets these criteria. Furthermore, colorectal cancer screening is recommended for average-risk adults aged 45 to 75. Because his last normal colonoscopy was exactly 10 years ago, he is due for repeat screening. Finally, ACIP guidelines state that adults aged 19 to 64 years with certain underlying medical conditions, such as diabetes mellitus and cigarette smoking, should receive a pneumococcal vaccine. As he is vaccine-naive for pneumococcus, administration of the 20-valent pneumococcal conjugate vaccine (PCV20) is indicated.

Adım Adım Çözüm

1
Assess the patient's age and smoking history to determine lung cancer screening eligibility.
The patient is 55 years old, has a 30-pack-year smoking history, and is a current smoker.
USPSTF guidelines require LDCT screening for adults aged 50-80 with a >=20 pack-year history who currently smoke or quit within 15 years.
2
Evaluate the need for colorectal cancer screening.
The patient is 55 and his last normal colonoscopy was 10 years ago.
Standard screening interval for average-risk adults following a normal colonoscopy is 10 years.
3
Review the patient's immunization history and comorbid conditions.
He has diabetes mellitus, is an active smoker, and has never received a pneumococcal vaccine.
ACIP recommends PCV20 for adults 19-64 with specific risk factors such as diabetes or smoking.
4
Evaluate the remaining options against guidelines.
Routine visual skin exam and repeat HCV screening without new risk factors are not routinely recommended by the USPSTF.
Skin cancer screening has insufficient evidence; HCV screening is generally a one-time test for average-risk adults.

Anahtar Kavram

Application of age- and risk-based USPSTF screening and ACIP immunization guidelines for adults in the primary care setting.
Soru 1053Soru →

A 4242-year-old woman is evaluated in the ambulatory clinic due to a three-day history of high fever, severe fatigue, and a painful sore throat. Her medical history is notable for Crohn disease, which has been in clinical remission for the past four years on a stable daily dose of azathioprine. She also has a history of recurrent gout. Three weeks ago, her primary care physician initiated febuxostat to better control her serum uric acid levels. Today, her temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 98/60 mmHg98/60\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 20/min20/\text{min}. Physical examination reveals pale conjunctivae and several aphthous ulcers on the buccal mucosa. There is no active joint swelling, erythema, or focal source of infection identified on examination.

Laboratory studies reveal:
Leukocyte count: 1,100/mm31,100/\text{mm}^3 (Absolute neutrophil count: 400/mm3400/\text{mm}^3)
Hemoglobin: 7.8 g/dL7.8\text{ g/dL}
Platelet count: 42,000/mm342,000/\text{mm}^3

Which of the following is the most appropriate next step in the evaluation and management of this patient?

Cevabı ve açıklamayı göster

Cevap: Admit to the hospital, discontinue azathioprine, and initiate empiric broad-spectrum intravenous antibiotics

Cevap

Admit to the hospital, discontinue azathioprine, and initiate empiric broad-spectrum intravenous antibiotics.
The correct action is to admit the patient to the hospital, discontinue azathioprine, and initiate empiric broad-spectrum intravenous antibiotics. This patient has febrile neutropenia (defined as a single oral temperature ≥38.3∘C\ge 38.3^\circ\text{C} or sustained temperature ≥38.0∘C\ge 38.0^\circ\text{C} for 11 hour, coupled with an absolute neutrophil count <500/mm3< 500/\text{mm}^3). This is a medical emergency. The underlying etiology is a severe pharmacokinetic interaction: azathioprine is a prodrug converted to 66-mercaptopurine (66-MP). 66-MP is subsequently degraded into inactive metabolites by the enzyme xanthine oxidase. Febuxostat (like allopurinol) is a xanthine oxidase inhibitor. When co-administered, febuxostat blocks the degradation of 66-MP, leading to massive intracellular accumulation of active thiopurine nucleotides and profound, life-threatening myelosuppression.

Adım Adım Çözüm

1
Evaluate the clinical presentation and vital signs.
The patient is febrile, tachycardic, hypotensive, and severely neutropenic (absolute neutrophil count <500/mm3<500/\text{mm}^3).
To identify that the patient is experiencing a hematologic emergency known as febrile neutropenia, which carries a high risk of rapid progression to septic shock.
2
Analyze the patient's medication list for pharmacokinetic interactions.
The patient was recently started on febuxostat while taking a stable dose of azathioprine.
To pinpoint the etiology of the sudden pancytopenia. Azathioprine is metabolized into 66-mercaptopurine, which is normally inactivated by xanthine oxidase. Febuxostat is a potent xanthine oxidase inhibitor, leading to toxic accumulation of 66-mercaptopurine and profound myelosuppression.
3
Determine the most appropriate setting and sequence for treatment evaluation.
Immediate inpatient admission, cessation of the interacting medications, and rapid administration of empiric broad-spectrum intravenous antibiotics are required.
Febrile neutropenia requires emergent stabilization before any further diagnostic workup (like imaging or biopsies) to prevent mortality.

Anahtar Kavram

Co-administration of azathioprine and xanthine oxidase inhibitors (such as febuxostat or allopurinol) results in a severe pharmacokinetic interaction leading to toxic accumulation of 66-mercaptopurine and life-threatening myelosuppression. The resulting febrile neutropenia is a medical emergency requiring immediate hospitalization and empiric broad-spectrum intravenous antibiotics.
Soru 1054Soru →

Presenting to the nephrology clinic with a 3-day history of hand tremors, headaches, and reduced urine output, a 52-year-old male recipient of a deceased-donor renal allograft undergoes urgent evaluation. He is currently 6 months post-transplantation.

His maintenance immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. Two weeks ago, he was diagnosed with oropharyngeal candidiasis by his primary care physician and completed a 14-day course of oral fluconazole.

Vital signs are:
ParameterValue
Temperature37.1°C (98.8°F)
Blood pressure158/96 mmHg
Pulse84/min

Physical examination reveals a fine resting tremor in the bilateral upper extremities. The transplanted kidney is non-tender to palpation.

Laboratory results:
TestResultReference Range
Potassium5.4 mEq/L3.5-5.0 mEq/L
Blood urea nitrogen48 mg/dL8-20 mg/dL
Serum creatinine3.1 mg/dL0.7-1.3 mg/dL

*Baseline serum creatinine was 1.3 mg/dL one month ago.*

Which of the following is the most appropriate next step in the management and monitoring of this patient?

Cevabı ve açıklamayı göster

Cevap: Order a serum tacrolimus trough level and withhold the next scheduled dose of tacrolimus

Cevap

The most appropriate next step is to order a serum tacrolimus trough level and withhold the next scheduled dose of tacrolimus.
This patient is presenting with acute calcineurin inhibitor (CNI) toxicity. Tacrolimus is metabolized primarily by the hepatic cytochrome P450 3A4 (CYP3A4) system. Fluconazole is a potent inhibitor of CYP3A4. The concurrent use of fluconazole drastically reduces tacrolimus clearance, leading to supratherapeutic levels. CNI toxicity manifests with dose-dependent acute kidney injury (due to afferent arteriolar vasoconstriction), new-onset or worsening hypertension, neurotoxicity (e.g., resting tremors, headaches, seizures), and metabolic derangements such as hyperkalemia. Because the clinical picture strongly points to drug toxicity rather than acute cellular rejection (which would typically present with graft tenderness and fever), the most appropriate next step in monitoring and evaluation is to withhold the next dose of tacrolimus and measure a serum trough level to confirm the diagnosis.

Adım Adım Çözüm

1
Analyze the patient's timeline and new medications.
The patient was recently started on fluconazole, a potent inhibitor of the cytochrome P450 (CYP3A4) enzyme system.
Identifying new medications is critical to uncovering drug-drug interactions in transplant patients.
2
Correlate the new medication with the maintenance regimen.
Tacrolimus is extensively metabolized by CYP3A4. Fluconazole inhibition leads to decreased tacrolimus clearance and supratherapeutic systemic levels.
Understanding the pharmacokinetic pathways reveals the mechanism of potential toxicity.
3
Evaluate the clinical presentation and laboratory results against known toxicities.
The patient exhibits classic signs of calcineurin inhibitor (CNI) toxicity: acute kidney injury (creatinine 3.1 mg/dL), neurotoxicity (tremors, headache), hypertension, and hyperkalemia.
Differentiating CNI toxicity from acute cellular rejection (which typically features graft tenderness and fever) dictates the management pathway.
4
Determine the optimal sequencing for treatment and monitoring.
The immediate priority is to halt the offending agent (withhold tacrolimus) and confirm the diagnosis non-invasively (check trough level) before pursuing invasive biopsies.
Standard of care requires establishing therapeutic drug levels before escalating to immunosuppressive therapies or invasive diagnostics.

Anahtar Kavram

Calcineurin inhibitor toxicity secondary to CYP3A4 inhibition requires immediate dose withholding and serum level monitoring before invasive diagnostics.
Tahmini Süre:2m 0s
Soru 1055Soru →

During morning rounds, an attending physician discusses discharge planning with a 64-year-old male patient who has end-stage heart failure (New York Heart Association class IV). The patient was hospitalized four days ago for a severe exacerbation and has been stabilized on intravenous diuretics, though he continues to experience dyspnea at rest. His recent echocardiogram demonstrates a left ventricular ejection fraction of 15%, and his cardiorenal syndrome has progressed to stage 4 chronic kidney disease. The patient states, "I am tired of coming to the hospital. I know my heart is giving out. I just want to go home and be comfortable, even if it means my time is short." The physician conducts a thorough evaluation and determines that the patient clearly understands his medical condition, prognosis, and the consequences of foregoing further acute care. Later that afternoon, the patient's adult daughter, who is his emergency contact, privately tells the physician, "He is just depressed because he's been in the hospital for days. You can't let him go home to die. I want him transferred to a rehabilitation center to get stronger. I am his daughter, and I have the right to decide this." Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Proceed with discharging the patient to home with community hospice services.

Cevap

Proceed with discharging the patient to home with community hospice services.
This patient has a terminal illness (end-stage heart failure and chronic kidney disease) and has clearly expressed a desire for comfort-focused care at home. The attending physician has evaluated the patient and determined that he has intact clinical decision-making capacity—meaning he fully understands his diagnosis, prognosis, and the consequences of his decisions. When a patient possesses clinical capacity, the ethical principle of autonomy dictates that their choices regarding medical care must be honored, even if family members strongly disagree. Therefore, the most appropriate next step is to respect the patient's autonomy and arrange for home hospice services as he requested.

Adım Adım Çözüm

1
Identify the patient's clinical status and articulated goals of care.
The patient has terminal heart failure and explicitly requests comfort-focused end-of-life care at home.
Establishing the patient's core medical status and wishes is the foundation for determining appropriate disposition.
2
Evaluate the patient's decision-making capacity based on the clinical assessment.
The attending physician has already confirmed that the patient understands his prognosis and the consequences of his decisions.
Before acting on a patient's wishes, it is necessary to ensure they possess the clinical capacity to make informed medical decisions.
3
Apply the principles of medical ethics regarding patient autonomy versus surrogate authority.
The daughter's demands cannot override the patient's choices, and the discharge should proceed as the patient requested.
A surrogate decision-maker is only activated when a patient loses capacity. Since this patient retains capacity, his autonomous decisions are legally and ethically binding.

Anahtar Kavram

In end-of-life care, a patient with intact clinical decision-making capacity has the paramount right to refuse life-prolonging care and dictate their disposition, superseding any objections from family members or designated surrogates.
Tahmini Süre:1m 30s
Soru 1056Soru →

An otherwise healthy 42-year-old woman visits the outpatient clinic for a scheduled check-up. She has no significant past medical history, takes no medications, and has no family history of cancer. She reports feeling completely well with no abdominal pain, bloating, or changes in bowel habits. However, she appears visibly distressed during the encounter. She states, "My best friend was just diagnosed with advanced ovarian cancer. I am terrified that I might have it too without knowing. I read online that there is a blood test for CA-125 and an ultrasound that can detect it early, and I want them done today." Which of the following is the most appropriate physician response?

Cevabı ve açıklamayı göster

Cevap: It is completely understandable to be frightened after your friend's diagnosis. Let's discuss how ovarian cancer screening works and why these specific tests are not recommended for you.

Cevap

The most appropriate response is to validate the patient's fear and initiate a discussion about why routine ovarian cancer screening is not recommended.
The correct approach to a patient expressing health anxiety driven by a peer's illness is to first validate their emotional distress using an empathetic statement, followed by patient education. According to the United States Preventive Services Task Force (USPSTF), routine screening for ovarian cancer with CA-125 and transvaginal ultrasound is strongly recommended against in asymptomatic, average-risk women. This is because screening does not reduce disease-specific mortality and carries a high risk of false-positive results, which can lead to unnecessary surgical interventions and severe psychological harm. By acknowledging the patient's fear and gently transitioning to a discussion of the medical evidence, the physician upholds both the therapeutic alliance and evidence-based practice.

Adım Adım Çözüm

1
Identify the patient's core concern and emotional state.
The patient is highly anxious about ovarian cancer due to a peer's recent diagnosis, despite having no symptoms or elevated risk factors.
Effective patient counseling requires addressing underlying emotions before delivering medical facts.
2
Evaluate the medical appropriateness of the requested intervention.
The USPSTF recommends against routine screening for ovarian cancer in asymptomatic, average-risk women because it does not reduce mortality and leads to harmful false positives.
Physicians must adhere to evidence-based preventive guidelines and avoid low-value care.
3
Select the communication strategy that merges empathy with education.
Acknowledge her understandable fear, then pivot to collaborative health education regarding why the tests are more likely to cause harm than benefit.
This maintains the therapeutic alliance while fulfilling the physician's duty to provide standard-of-care medical advice.

Anahtar Kavram

Empathetic communication and evidence-based patient education in the setting of low-value care requests.

Alternatif Yöntem

When addressing requests for low-value care, use the 'NURSE' mnemonic for empathy (Name, Understand, Respect, Support, Explore) followed by the 'Ask-Tell-Ask' framework for delivering health information.
Tahmini Süre:1m 0s
Soru 1057Soru →

Match each patient statement or scenario representing a stage in the Transtheoretical Model of Change (left) with the most appropriate physician counseling strategy (right).

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old man with alcoholic hepatitis says, "I know drinking is hurting my liver, but I really enjoy socializing with my friends at the bar."
A 32-year-old woman says, "I bought a gym membership and new running shoes yesterday, but I am not sure exactly when I will start working out."
A 55-year-old man with uncontrolled hypertension says, "I feel perfectly fine, so I do not see why I need to take these blood pressure pills."
A 28-year-old woman says, "I stopped vaping three months ago, but sometimes I still get strong urges when I am stressed at work."

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios match their respective stages of change: Precontemplation (unaware of problem) matches with providing information without pressure; Contemplation (ambivalent) matches with exploring pros and cons; Preparation (getting ready) matches with setting a specific start date; Action (recently changed) matches with relapse prevention and coping strategies.
Matching the counseling strategy to the patient's specific readiness stage maximizes the effectiveness of the intervention. Precontemplation requires gentle awareness-building; contemplation requires exploring ambivalence; preparation requires concrete planning; and action requires relapse prevention.

Adım Adım Çözüm

1
Analyze the hypertension patient's statement.
The patient feels fine and sees no reason for medication (Precontemplation).
Identifying the stage of change dictates the counseling approach, which should focus on raising awareness without confrontation.
2
Analyze the alcoholic hepatitis patient's statement.
The patient knows drinking is harmful but enjoys the social aspect (Contemplation).
Recognizing ambivalence directs the physician to explore the pros and cons to help the patient resolve their indecision.
3
Analyze the gym membership patient's statement.
The patient has taken initial steps but hasn't fully started (Preparation).
Patients in this stage benefit most from concrete planning and establishing a firm start date.
4
Analyze the vaping cessation patient's statement.
The patient has maintained the change for three months but faces triggers (Action).
During the action phase, the primary goal is relapse prevention through the development of coping skills.

Anahtar Kavram

Transtheoretical Model (Stages of Change) and Stage-Matched Interventions
Soru 1058Soru →

Match each ambulatory patient presentation with the most appropriate next step in preventive care and screening according to current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 35-year-old male presents for a wellness visit. He is asymptomatic. His father was recently diagnosed with colorectal cancer at age 42. He has never undergone endoscopic screening.
A 68-year-old female presents for an annual examination. She has never smoked and has no cardiovascular history. She asks if she needs an ultrasound to screen for an abdominal aortic aneurysm.
A 28-year-old female at 28 weeks gestation in her second pregnancy presents for routine prenatal care. She received all recommended vaccines, including Tdap, during her first pregnancy three years ago.
A 62-year-old female presents for a health maintenance visit. She underwent a total abdominal hysterectomy for benign uterine leiomyomas five years ago. Prior cervical cytology results were consistently normal.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align each patient with their specific evidence-based preventive intervention: The 35-year-old male requires immediate colonoscopy with 5-year surveillance; the 68-year-old female never-smoker requires no AAA screening; the pregnant female requires a Tdap vaccine regardless of prior doses; and the post-hysterectomy female should discontinue cervical screening.
Each presentation tests a specific caveat to routine screening and vaccination guidelines. High-risk colorectal screening requires initiation 10 years before the youngest affected first-degree relative and requires 5-year colonoscopy intervals. AAA screening is actively recommended against in female never-smokers. Tdap is mandated for every pregnancy to protect the newborn, irrespective of the mother's standard 10-year booster status. Total hysterectomy for benign indications necessitates the cessation of Pap smears.

Adım Adım Çözüm

1
Analyze the 35-year-old male's family history of colorectal cancer.
Identify that a first-degree relative diagnosed at age 42 dictates screening initiation at age 32 (10 years prior) with a colonoscopy every 5 years.
High-risk family history alters both the initiation age and the interval of colorectal cancer screening.
2
Evaluate the 68-year-old female's request for an abdominal aortic aneurysm (AAA) screening.
Determine that AAA screening is contraindicated.
Guidelines strictly recommend against AAA screening in females who have never smoked due to negligible benefit and potential harm from incidental findings.
3
Assess the vaccination requirements for the 28-year-old female at 28 weeks gestation.
Determine she requires a Tdap vaccine today despite having received one 3 years ago.
Maternal pertussis antibodies wane quickly; a new dose is required during the 27-36 week window of every pregnancy to protect the neonate.
4
Review the 62-year-old female's surgical and screening history.
Conclude that cervical cancer screening can be permanently discontinued.
A total hysterectomy for benign disease (e.g., leiomyomas) removes the cervix, eliminating the need for screening in the absence of a high-grade dysplastic history.

Anahtar Kavram

Application of preventive care exceptions based on high-risk family history, patient sex and smoking status, pregnancy, and past surgical history.
Soru 1059Soru →

A 71-year-old male with a history of ischemic cardiomyopathy is evaluated in the hospital. Three years ago, he received a left ventricular assist device (LVAD) as destination therapy, along with an implantable cardioverter-defibrillator (ICD). He was recently admitted with progressive jaundice, weight loss, and severe abdominal pain, and has just been diagnosed with widely metastatic pancreatic adenocarcinoma. Oncology evaluation concludes he is not a candidate for disease-directed therapy due to his poor performance status and advanced disease stage.

The patient is fully alert, conversant, and demonstrates intact decision-making capacity. He expresses a clear desire to focus exclusively on comfort, wishes to avoid any further life-prolonging or painful interventions, and wants to return home with hospice services. He emphasizes a strong fear of experiencing severe shortness of breath or painful shocks during his final days. His current hemodynamics are stable on his baseline LVAD settings, and he is not experiencing dyspnea at rest.

Which of the following is the most appropriate next step in the management of his cardiac devices?

Cevabı ve açıklamayı göster

Cevap: Deactivate the defibrillator function of the implantable cardioverter-defibrillator while continuing left ventricular assist device support.

Cevap

Deactivate the defibrillator function of the implantable cardioverter-defibrillator while continuing left ventricular assist device support.
The correct approach balances the patient's desire for comfort and his fear of dyspnea. Deactivating the ICD's defibrillator function eliminates the risk of painful shocks during the dying process, aligning with comfort goals. Conversely, maintaining the LVAD is crucial because it actively prevents the acute pulmonary edema and severe shortness of breath that would rapidly ensue if the device were turned off. This strategy provides optimal palliative symptom control while honoring the patient's wish for a peaceful death at home.

Adım Adım Çözüm

1
Identify the patient's primary goals of care.
The patient wants purely comfort-focused care at home, specifically avoiding painful interventions and severe shortness of breath.
All medical management decisions at the end of life must be guided by the patient's articulated values and goals.
2
Evaluate the role of the implantable cardioverter-defibrillator (ICD) in the context of these goals.
The defibrillator function of the ICD delivers painful shocks to prevent sudden cardiac death. This conflicts with the goal of comfort and a natural death.
Painful life-prolonging interventions are contraindicated when the goal is strict comfort.
3
Evaluate the role of the left ventricular assist device (LVAD) in the context of these goals.
The LVAD maintains forward blood flow and prevents backward failure. Deactivating it would likely cause acute pulmonary edema and severe dyspnea, which the patient explicitly fears.
Interventions that provide significant symptom relief (palliative benefit) should be maintained even in hospice care.

Anahtar Kavram

Management of cardiac devices at the end of life requires differentiating between interventions that cause pain and prolong the dying process (like ICD shocks, which should be deactivated) and those that provide palliative symptom relief (like LVADs preventing dyspnea, which can be maintained).
Soru 1060Soru →

Match each palliative care clinical scenario with the most appropriate pharmacological intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

An 81-year-old with end-stage renal disease and diffuse bone metastases is tolerating 60 mg of oral morphine equivalents daily but requires transition to a continuous, long-acting analgesic for severe pain.
A 67-year-old with metastatic prostate cancer whose opioid dosage was rapidly escalated over three days now presents with new-onset delirium, diffuse hyperalgesia, and spontaneous myoclonic jerks.
A 78-year-old actively dying patient appears comfortable but exhibits loud, pooling oropharyngeal secretions during inspiration and expiration that are highly distressing to the family at the bedside.
A 62-year-old opioid-naïve patient with end-stage interstitial lung disease experiences severe air hunger and tachypnea at rest despite maximal supplemental oxygen therapy.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match the end-stage renal disease patient with a transdermal fentanyl patch, the patient exhibiting neurotoxicity with an opioid rotation, the actively dying patient having terminal secretions with glycopyrrolate, and the opioid-naïve dyspneic patient with low-dose oral morphine.
Each pairing directly addresses specific physiological limitations and symptom profiles commonly encountered in palliative care. Fentanyl avoids the accumulation of toxic metabolites in renal failure and is safe due to the patient's existing opioid tolerance. Opioid rotation clears the neurotoxic metabolites causing myoclonus and hyperalgesia. Glycopyrrolate dries terminal secretions without causing central nervous system agitation. Low-dose oral morphine safely targets the central perception of dyspnea in pulmonary failure.

Adım Adım Çözüm

1
Evaluate the patient with end-stage renal disease for appropriate continuous analgesia.
The patient is matched with initiating a transdermal fentanyl patch.
Morphine metabolites accumulate in renal failure, causing toxicity. Fentanyl is safe in renal impairment and is indicated here because the patient is already opioid-tolerant.
2
Identify the cause of the cancer patient's hyperalgesia and myoclonus.
The patient is matched with performing an opioid rotation.
The clinical picture is opioid-induced neurotoxicity. Management requires rotating to a structurally distinct opioid to allow clearance of the accumulated neurotoxic metabolites.
3
Determine the pharmacological treatment for the dying patient's noisy breathing.
The patient is matched with administering subcutaneous glycopyrrolate.
Glycopyrrolate dries terminal secretions effectively and, unlike other anticholinergics, does not cross the blood-brain barrier to cause confusion or agitation.
4
Select the best intervention for the opioid-naïve patient's refractory air hunger.
The patient is matched with initiating low-dose targeted oral morphine.
Systemic opioids are the gold standard for alleviating severe terminal dyspnea. An immediate-release oral formulation is appropriate and safe for an opioid-naïve patient when titrated carefully.

Anahtar Kavram

Pharmacological symptom management in palliative care requires individualizing therapy based on organ function (e.g., using fentanyl over morphine in renal failure), symptom etiology (e.g., low-dose opioids for dyspnea, anticholinergics for terminal secretions), and opioid tolerance.
ÖncekiSayfa 53 / 104Sonraki